A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy

Journal of Nephrology

Volumn 29, Issue 3, 2016, Pages 277-303

  Cabiddu, Gianfranca ^a   Castellino, Santina ^b   Gernone, Giuseppe ^c   Santoro, Domenico ^d   Moroni, Gabriella ^e   Giannattasio, Michele ^f   Gregorini, Gina ^g   Giacchino, Franca ^h   Attini, Rossella ⁱ   Loi, Valentina ^a   Limardo, Monica ^j   Gammaro, Linda ^k   Todros, Tullia ⁱ   Piccoli, Giorgina Barbara ^l,m  

^a BROTZU HOSPITAL   (Italy)

^b Hospital of Taormina   (Italy)

^c Department of Medical Oncology   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f POLICLINICO   (Italy)

^g SPEDALI CIVILI   (Italy)

^h Ospedale d Ivrea   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j Azienda Ospedaliera della Provincia di Lecco   (Italy)

^k Section of Onco Hematology   (Italy)

^l UNIVERSITY OF TURIN   (Italy)

^m CENTRE HOSPITALIER DU MANS   (France)

more..

Author keywords

Chronic kidney disease; Evidence based medicine; Hypertension; Pre term delivery; Preeclampsia; Pregnancy; Proteinuria

Indexed keywords

ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FETUS MALFORMATION; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MATERNAL MORTALITY; NEPHROLITHIASIS; PREECLAMPSIA; PREGNANCY; PROTEINURIA; PULMONARY VASCULITIS; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFLUX NEPHROPATHY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; COMPLICATION; EVIDENCE BASED MEDICINE; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL DEATH; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC;

DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; FEMALE; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MATERNAL DEATH; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84969922350     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-016-0285-6     Document Type: Review

References (370)

1. (1975) Pregnancy and renal disease. Lancet 2(7939):801–802
2. Duffy D, Reynolds P (2011) Babies born at the threshold of viability: attitudes of paediatric consultants and trainees in South East England. Acta Paediatr 100(1):42–46
3. Hale TM, Arul M, Veerappan A, Nguyen J, Velastegui Z, Shiffman R, Rajegowda B, Skupski D, Mercado R (2011) Predicting survival of periviable fetuses using NICHD fetal heart rate categories. J Perinat Med 39(1):47–50
4. Stephens BE, Tucker R, Vohr BR (2010) Special health care needs of infants born at the limits of viability. Pediatrics 125(6):1152–1158
5. Hou SH (1994) Pregnancy in women on haemodialysis and peritoneal dialysis. Baillieres Clin Obstet Gynaecol 8:481–500
6. Piccoli GB, Conijn A, Consiglio V et al (2010) Pregnancy in dialysis patients: is the evidence strong enough to lead us to change our counseling policy? Clin J Am Soc Nephrol 5:62–71
7. Hladunewich MA, Hou S, Odutayo A et al (2014) Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States Cohort Comparison. J Am Soc Nephrol 25(5):1103–1109
8. Toma H, Tanabe K, Tokumoto T, Kobayashi C, Yagisawa T (1999) Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey. Nephrol Dial Transplant 14:1511–1516
9. Luders C, Castro MC, Titan SM et al (2010) Obstetric outcome in pregnant women on long-term dialysis: a case series. Am J Kidney Dis 56:77–85
10. Jesudason S, Grace BS, McDonald SP (2014) Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol 9:143–149
11. Piccoli GB, Cabiddu G, Daidone G et al (2014) The children of dialysis: live-born babies from on-dialysis mothers in Italian epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol Dial Transplant 29(8):1578–1586
12. Piccoli GB, Postorino V, Cabiddu G et al (2015) ‘Kidney and Pregnancy Study Group’ of the ‘Italian Society of Nephrology’. Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: a multicentre nationwide study 2000–12. Nephrol Dial Transplant 30(7):1193–1202
13. Cabiddu G, Castellino S, Gernone G et al (2015) Kidney and Pregnancy Study Group of Italian Society of Nephrology. Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy. J Nephrol 28(3):279–288
14. www.kidney.org. Accessed 20 Sept 2015
15. Winearls CG, Glassock RJ (2009) Dissecting and refining the staging of chronic kidney disease. Kidney Int 75:1009–1014
16. Smyth A, Radovic M, Garovic VD (2013) Women, kidney disease, and pregnancy. Adv Chronic Kidney Dis 20:402–410
17. Davison JM, Lindheimer MD (2011) Pregnancy and chronic kidney disease. Semin Nephrol 31:86–99
18. Williams D, Davison J (2008) Chronic kidney disease in pregnancy. BMJ 33:211–215
19. Nevis IF, Reitsma A, Dominic A et al (2011) Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol 6:2587–2598
20. Piccoli GB, Conijn A, Attini R et al (2011) Pregnancy in chronic kidney disease: need for a common language. J Nephrol 24:282–299
21. Zhang JJ, Ma XX, Hao L, Liu LJ, Lv JC, Zhang H (2015) A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD Outcomes in pregnancy. Clin J Am Soc Nephrol 10(11):1964–1978
22. Lateef A, Petri M (2013) Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 27:435–447
23. Stanhope TJ, White WM, Moder KG et al (2012) Obstetric nephrology: lupus and lupus nephritis in pregnancy. Clin J Am Soc Nephrol 7:2089–2099
24. Vora N, Perrone R, Bianchi DW (2008) Reproductive issues for adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 5:307–518
25. Chapman AB, Johnson AM, Gabow PA (1994) Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5(5):1178–1185
26. Schneeberger C, Geerlings SE, Middleton P, Crowther CA (2012) Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev 11:CD009279
27. Podymow T, August P, Akbari A (2010) Management of renal disease in pregnancy. Obstet Gynecol Clin N Am 37(2):195–210
28. Piccoli GB, Clari R, Ghiotto S et al (2013) Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study. Rev Diabet Stud 10:6–26
29. Piccoli GB, Tavassoli E, Melluzza C et al (2013) Severe diabetic nephropathy in type 1 diabetes and pregnancy—a case series. Rev Diabet Stud 10:68–78
30. Bramham K, Rajasingham D (2012) Pregnancy in diabetes and kidney disease. J Ren Care 38(Suppl 1):78–89
31. Garovic VD (2000) Hypertension in pregnancy: diagnosis and treatment. Mayo Clin Proc 75(10):1071–1076
32. Piccoli GB, Fassio F, Attini R et al (2012) Pregnancy in CKD: whom should we follow and why? Nephrol Dial Transplant 27(Suppl 3):iii111–iii118
33. Morikawa M, Yamada T, Minakami H (2009) Outcome of pregnancy in patients with isolated proteinuria. Curr Opin Obstet Gynecol 21(6):491–495
34. Smith MC, Moran P, Ward MK, Davison JM (2008) Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG 115:109–112
35. Krutzén E, Olofsson P, Bäck SE, Nilsson-Ehle P (1992) Glomerular filtration rate in pregnancy: a study in normal subjects and in patients with hypertension, preeclampsia and diabetes. Scand J Clin Lab Invest 52:387–392
36. Ahmed SB, Bentley-Lewis R, Hollenberg NK et al (2009) A comparison of prediction equations for estimating glomerular filtration rate in pregnancy. Hypertens Pregnancy 28:243–255
37. Alper AB, Yi Y, Rahman M, Webber LS et al (2011) Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients. Am J Perinatol 28(6):425–430
38. Piccoli GB, Attini R, Vigotti FN et al (2015) Is renal hyperfiltration protective in chronic kidney disease-stage 1 pregnancies? A step forward unravelling the mystery of the effect of stage 1 chronic kidney disease on pregnancy outcomes. Nephrology (Carlton) 20(3):201–208
39. Gülmezoglu M, Villar J, Hofmeyr J, Duley L, Belizan JM (1998) Randomised trials in maternal and perinatal medicine: global partnerships are the way forward. Br J Obstet Gynaecol 105(12):1244–1247
40. Patel D, Nasir S, Elati A, Vernon G, Weeks AD (2012) Historical trends in the timing of informed consent for research into intrapartum complications. BJOG 119(3):361–365
41. Johnson A (1997) Randomised controlled trials in perinatal medicine: 3. Identifying and measuring endpoints in randomised controlled trials. Br J Obstet Gynaecol 104(7):768–771
42. Barton S (2000) Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ. 321(7256):255–256
43. Devereaux PJ, Yusuf S (2003) The evolution of the randomized controlled trial and its role in evidence-based decision making. J Intern Med 254(2):105–113
44. Barnhart K, Sammel M (2002) The truth is out there: a guide to the pitfalls of interpreting evidence-based medicine in studies of human reproduction. Fertil Steril 77(2):223–228
45. Feigin VL, Howard G (2008) The importance of epidemiological studies should not be downplayed. Stroke 39(1):1–2
46. La Caze A (2009) Evidence-based medicine must be. J Med Philos 34(5):509–527
47. Thompson RP (2010) Causality, mathematical models and statistical association: dismantling evidence-based medicine. J Eval Clin Pract 16(2):267–275
48. Mansouri A, Cooper B, Shin SM, Kondziolka D (2015) Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered? J Neurosurg 28:1–11
49. Hou SH, Grossman SD, Madias NE (1985) Pregnancy in women with renal disease and moderate renal insufficiency. Am J Med 78:185–194
50. Jungers P, Forget D, Henry-Amar M et al (1986) Chronic kidney disease and pregnancy. Adv Nephrol Necker Hosp 15:103–141
51. Jones DC, Hayslett JP (1996) Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 335:226–232
52. Bramham K, Briley AL, Seed PT et al (2011) Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod Sci 18:623–630
53. Imbasciati E, Gregorini G, Cabiddu G et al (2007) Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis 49:753–762
54. Epstein FH (1996) Pregnancy and renal disease. N Engl J Med 335:277–278
55. Chopra S, Suri V, Aggarwal N et al (2009) Pregnancy in chronic renal insufficiency: single centre experience from North India. Arch Gynecol Obstet 279:691–695
56. Piccoli GB, Attini R, Vasario E et al (2010) Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol 5:844–855
57. Ibrahim HN, Akkina SK, Leister E et al (2009) Pregnancy outcomes after kidney donation. Am J Transplant 9:825–834
58. Reisaeter AV, Røislien J, Henriksen T et al (2009) Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant 9:820–824
59. Alsuwaida A, Mousa D, Al-Harbi A et al (2011) Impact of early chronic kidney disease on maternal and fetal outcomes of pregnancy. J Matern Fetal Neonatal Med 24:1432–1436
60. Limardo M, Imbasciati E, Ravani P et al (2010) Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study. Am J Kidney Dis 56:506–512
61. Bramham K, Lightstone L (2012) Pre-pregnancy counseling for women with chronic kidney disease. J Nephrol 25:450–459
62. Piccoli GB, Cabiddu G, Attini R et al (2015) Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26(8):2011–2022
63. Alkhunaizi A, Melamed N, Hladunewich MA (2015) Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens 24(3):252–259
64. Singh R, Prasad N, Banka A, Gupta A, Bhadauria D, Sharma RK, Kaul A (2015) Pregnancy in patients with chronic kidney disease: maternal and fetal outcomes. Indian J Nephrol 25(4):194–199
65. Feng Z, Minard C, Raghavan R (2015) Pregnancy outcomes in advanced kidney disease. Clin Nephrol 83(5):272–278
66. Kendrick J, Sharma S, Holmen J, Palit S, Nuccio E, Chonchol M (2015) Kidney disease and maternal and fetal outcomes in pregnancy. Am J Kidney Dis 66(1):55–59
67. Garg AX, Nevis IF, McArthur E et al (2015) DONOR Network. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 372(2):124–133
68. Pagnoux C, Mahendira D, Laskin CA (2013) Fertility and pregnancy in vasculitis. Best Pract Res Clin Rheumatol 27:79–94
69. Smyth A, Oliveira GH, Lahr BD et al (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5:2060–2068
70. Ritchie J, Smyth A, Tower C et al (2012) Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus 21:534–541
71. Biesenbach G, Stoger H, Zazgornik J (1992) Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type 1 diabetic patients with impaired renal function. Nephrol Dial Transplant 7:105–109
72. Mathiesen ER, Ringholm L, Feldt-Rasmussen B, Clausen P, Damm P (2012) Obstetric nephrology: pregnancy in women with diabetic nephropathy—the role of antihypertensive treatment. Clin J Am Soc Nephrol 7(12):2081–2088
73. Bramham K, Rajasingham D (2012) Pregnancy in diabetes and kidney disease. J Ren Care 38(1):78–89
74. Hawthorne G (2011) Maternal complications in diabetic pregnancy. Best Pract Res Clin Obstet Gynaecol 25(1):77–90
75. Vohr B (2013) Long-term outcomes of moderately preterm, late preterm, and early term infants. Clin Perinatol 40(4):739–751
76. Asano MK, Dray PB (2014) Retinopathy of prematurity. Dis Mon 60(6):282–291
77. Sutherland MR, Bertagnolli M, Lukaszewski MA, Huyard F, Yzydorczyk C, Luu TM, Nuyt AM (2014) Preterm birth and hypertension risk: the oxidative stress paradigm. Hypertension 63(1):12–18
78. Kugelman A, Colin AA (2013) Late preterm infants: near term but still in a critical developmental time period. Pediatrics 132(4):741–751
79. Gubhaju L, Sutherland MR, Black MJ (2011) Preterm birth and the kidney: implications for long-term renal health. Reprod Sci 18:322–333
80. Sutherland MR, Gubhaju L, Moore L et al (2011) Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 22:1365–1374
81. Hodgin JB, Rasoulpour M, Markowitz GS, D’Agati VD (2009) Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 4:71–76
82. Carmody JB, Charlton JR (2013) Short-term gestation, long-term risk: prematurity and chronic kidney disease. Pediatrics 131:1168–1179
83. Abitbol CL, Rodriguez MM (2012) The long-term renal and cardiovascular consequences of prematurity. Nat Rev Nephrol 8(5):265–274
84. Janvier A, Lorenz JM, Lantos JD (2012) Antenatal counseling for parents facing an extremely preterm birth: limitations of the medical evidence. Acta Paediatr 101(8):800–804
85. Stelloh C, Allen KP, Mattson DL, Lerch-Gaggl A, Reddy S, El-Meanawy A (2012) Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Transl Res 159(2):80–89
86. Roggero P, Giannì ML, Garbarino F, Mosca F (2013) Consequences of prematurity on adult morbidities. Eur J Intern Med 24(7):624–626
87. Luyckx VA, Brenner BM (2005) Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 97:S68–S77
88. Luyckx VA, Brenner BM (2010) The clinical importance of nephron mass. J Am Soc Nephrol 21:898–910
89. Parkinson JR, Hyde MJ, Gale C, Santhakumaran S, Modi N (2013) Preterm birth and the metabolic syndrome in adult life: a systematic review and meta-analysis. Pediatrics 131(4):e1240–e1263
90. de Jong F, Monuteaux MC, van Elburg RM, Gillman MW, Belfort MB (2012) Systematic review ant meta-analysis of preterm birth and later systolic blood pressure. Hypertension 59:226–234
91. Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J (2012) Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia 55:936–947
92. Piccoli GB, Arduino S, Attini R et al (2013) Multiple pregnancies in CKD patients: an explosive mix. Clin J Am Soc Nephrol 8:41–50
93. Hladunewich MA, Steinberg G, Karumanchi SA et al (2009) Angiogenic factor abnormalities and fetal demise in a twin pregnancy. Nat Rev Nephrol 5:658–662
94. Loeffler CL, Macri CJ, Bathgate SL, Freese L, Larsen JW (2005) Autosomal dominant polycystic kidney disease in pregnancy complicated by twin gestation and severe preeclampsia: a case report. J Reprod Med 50(5):370–372
95. Gizzo S, Noventa M, Saccardi C, Paccagnella G, Patrelli TS, Cosmi E, D’Antona D (2014) Twin pregnancy after kidney transplantation: what’s on? A case report and review of literature. J Matern Fetal Neonatal Med 27(17):1816–1819
96. Abou-Jaoude P, Dubourg L, Bessenay L et al (2012) What about the renal function during childhood of children born from dialysed mothers? Nephrol Dial Transplant 27:2365–2369
97. Blowey DL, Warady BA (2007) Outcome of infants born to women with chronic kidney disease. Adv Chronic Kidney Dis 14:199–205
98. Banerjee I, Powis S, Shevlin M, Barnes J, Soo A, Sutcliffe AG (2010) Health outcomes of children born to mothers with chronic kidney disease: a pilot study. Pediatr Rep 2(1):e7
99. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376:631–644
100. Masuyama H, Nobumoto E, Okimoto N, Inoue S, Segawa T, Hiramatsu Y (2012) Superimposed preeclampsia in women with chronic kidney disease. Gynecol Obstet Invest 74(4):274–281
101. Brown MA (2014) Pre-eclampsia in 2014: seven ways to make a difference. Pregnancy Hypertens 4(4):249–252
102. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P (2014) Canadian hypertensive diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Disorders of Pregnancy (HDP) Working Group. Pregnancy Hypertens 4(2):105–145
103. Tranquilli AL (2013) Introduction to ISSHP new classification of preeclampsia. Pregnancy Hypertens 3(2):58–59
104. Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM (2013) The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens 3(1):44–47
105. Rezk M, Gamal A, Emara M (2015) Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study. Hypertens Pregnancy 34(2):137–144
106. Berks D, Steegers EA, Molas M, Visser W (2009) Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol 114(6):1307–1314
107. Umans JG (2012) Obstetric nephrology: preeclampsia—the nephrologist’s perspective. Clin J Am Soc Nephrol 7(12):2107–2113
108. Lisonkova S, Joseph KS (2013) Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 209:544.e1–544.e12
109. Arulkumaran N, Lightstone L (2013) Severe pre-eclampsia and hypertensive crises. Best Pract Res Clin Obstet Gynaecol 27(6):877–884
110. Ciantar E, Walker JJ (2011) Pre-eclampsia, severe pre-eclampsia and hemolysis, elevated liver enzymes and low platelets syndrome: what is new? Womens Health 7(5):555–569
111. Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga A (2011) Delayed post partum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol 118(5):1102–1107
112. Mikami Y, Takagi K, Itaya Y, Ono Y, Matsumura H, Takai Y, Seki H (2014) Post-partum recovery course in patients with gestational hypertension and pre-eclampsia. J Obstet Gynaecol Res. 40(4):919–925
113. McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ (2010) Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 55(6):1026–1039
114. Wu CC, Chen SH, Ho CH, Liang FW, Chu CC, Wang HY, Lu YH (2014) End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol 210(2):147
115. Rolfo A, Attini R, Nuzzo AM et al (2013) Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int 83(1):177–181
116. http://www.acog.org/Resources_And_Publications/Task_Force_and_Work_Group_Reports/Hypertension_in_Pregnancy. Accessed 15 Sept 2015
117. Piccoli GB, Gaglioti P, Attini R et al (2013) Pre-eclampsia or chronic kidney disease? The flow hypothesis. Nephrol Dial Transplant 28(5):1199–1206
118. Parra M, Rodrigo R, Barja P, Bosco C, Fernández V, Muñoz H, Soto-Chacón E (2005) Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 193(4):1486–1491
119. Papageorghiou AT, Roberts N (2005) Uterine artery Doppler screening for adverse pregnancy outcome. Curr Opin Obstet Gynecol 17(6):584–590
120. Gaillard R, Arends LR, Steegers EA, Hofman A, Jaddoe VW (2013) Second- and third-trimester placental hemodynamics and the risks of pregnancy complications: the Generation R Study. Am J Epidemiol 177(8):743–754
121. Kane SC, Dennis AT (2015) Doppler assessment of uterine blood flow in pre-eclampsia: a review. Hypertens Pregnancy 34(4):400–421
122. Levine RJ, Maynard SE, Qian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350(7):672–683
123. von Dadelszen P, Payne B, Li J, PIERS Study Group et al (2011) Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 377(9761):219–227
124. Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565
125. Garovic VD, Wagner SJ, Turner ST et al (2007) Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 196(4):320.e1-7
126. White WM, Garrett AT, Craici IM et al (2014) Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS One 9(3):e92693
127. Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS (2006) Tests in Prediction of Pre-eclampsia Severity review group. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG 113(4):369–378
128. Dusse LM, Alpoim PN, Lwaleed BA et al (2013) Is there a link between endothelial dysfunction, coagulation activation and nitric oxide synthesis in preeclampsia? Clin Chim Acta 16(415):226–229
129. George EM, Granger JP (2011) Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 24(9):964–969
130. Bilodeau JF (2014) Review: maternal and placental antioxidant response to preeclampsia—impact on vasoactive eicosanoids. Placenta 35(Suppl):S32–S38
131. Gennari-Moser C, Khankin EV, Escher G et al (2013) Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia. Hypertension 61(5):1111–1117
132. Rana S, Powe CE, Salahuddin S et al (2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125(7):911–919
133. Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE (2007) Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 197(3):244.e1-8
134. Duhig KE, Chappell LC, Shennan AH (2014) How placental growth factor detection might improve diagnosis and management of pre-eclampsia. Expert Rev Mol Diagn 14(4):403–406
135. Verlohren S, Herraiz I, Lapaire O et al (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206(1):58.e1-8
136. Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, EBM CONNECT Collaboration et al (2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 119(7):778–787
137. Powers RW, Jeyabalan A, Clifton RG, Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network et al (2010) Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 5(10):e13263
138. Forest JC, Thériault S, Massé J, Bujold E, Giguère Y (2014) Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women. Clin Chem Lab Med 52(8):1169–1178
139. Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, Gómez-Montes E, Denk B, Galindo A (2013) Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia. Ultrasound Obstet Gynecol 41(5):530–537
140. Piccoli GB, Daidola G, Attini R et al (2013) Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. BJOG 120:412–427
141. Magee LA, Pels A, Helewa M et al (2014) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 36:416–438
142. Abalos E, Duley L, Steyn DW (2014) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2:CD002252
143. Molvi SN, Mir S, Rana VS et al (2012) Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Arch Gynecol Obstet 285:1553–1562
144. Rothberger S, Carr D, Brateng D, Hebert M, Easterling TR (2010) Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens 23:1234–1240
145. Collins R, Yusuf S, Peto R (1985) Overview of randomised trials of diuretics in pregnancy. Br Med J 290:17–23
146. Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, von Dadelszen P (2014) Community Level Interventions for Pre-eclampsia (CLIP) Working Group. BJOG 121(10):1210–1218
147. Nabhan AF, Elsedawy MM (2011) Tight control of mild-moderate pre-existing or non-proteinuric gestational hypertension. Cochrane Database Syst Rev 7:CD006907
148. Magee LA, von Dadelszen P, Rey E et al (2015) Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372(5):407–417
149. Magee LA, CHIPS Study Group et al, von Dadelszen P et al (2015) Control of hypertension in pregnancy study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa? BJOG. doi:10.1111/1471-0528.13568
150. Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, von Dadelszen P, Community Level Interventions for Pre-eclampsia (CLIP) Working Group (2014) Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG 121(10):1210–1218 (discussion 1220)
151. Wise J (2015) Tight blood pressure control during pregnancy offers no clear benefits, study finds. BMJ 2(350):h549
152. Huynh K (2015) Hypertension: tight control of hypertension is safe in pregnant women. Nat Rev Cardiol 12(4):196
153. Koren G (2011) Hypertension: ACE inhibitor use in pregnancy—setting the record straight. Nat Rev Cardiol. 9(1):7–8. doi:10.1038/nrcardio.2011.179
154. Lewis G, Maxwell AP (2014) Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Diabetologia 57(5):1082–1083
155. Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451
156. Li DK, Yang C, Andrade S, Tavares V, Ferber JR (2011) Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343:d5931
157. Vasilakis-Scaramozza C, Aschengrau A, Cabral HJ, Jick SS (2013) Antihypertensive drugs and the risk of congenital anomalies. Pharmacotherapy 33:476–482
158. Al-Balas M, Bozzo P, Einarson A (2009) Use of diuretics during pregnancy. Can Fam Physician 55(1):44–45
159. Henderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH, Rowland MG (2014) Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. US Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews
160. Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, Ebrashy A, Bujold E (2012) Early administration of low-dose aspirin for the prevention of preterm and termpreeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 31(3):141–146
161. Bujold E, Roberge S, Lacasse Y et al (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116(2 Pt 1):402–414
162. Roberge S, Villa P, Nicolaides K et al (2012) Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 31(3):141–146
163. Roberge S, Giguère Y, Villa P et al (2012) Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 29(7):551–556
164. Boldt J (2010) Use of albumin: an update. Br J Anaesth 104:276–284
165. Jouppila P, Jouppila R, Koivula A (1983) Albumin infusion does not alter the intervillous blood flow in severe pre-eclampsia. Acta Obstet Gynecol Scand 62(4):345–348
166. Fliser D, Zurbrüggen I, Mutschler E et al (1999) Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55(2):629–634
167. Elwell RJ, Spencer AP, Eisele G (2003) Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 37(5):695–700
168. Piccoli GB, Attini R, Vasario E et al (2011) Vegetarian supplemented low-protein diets. A safe option for pregnant CKD patients: report of 12 pregnancies in 11 patients. Nephrol Dial Transplant 26(1):196–205
169. Piccoli GB, Leone F, Attini R et al (2014) Association of low-protein supplemented diets with fetal growth in pregnant women with CKD. Clin J Am Soc Nephrol. 9(5):864–873
170. Cahill LE, Peng CY, Bankovic-Calic N, Sankaran D, Ogborn MR, Aukema HM (2007) Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring. Br J Nutr 97:77–84
171. Barsotti G, Morelli E, Cupisti A, Meola M, Dani L, Giovannetti SA (1996) Low-nitrogen low-phosphorus Vegan diet for patients with chronic renal failure. Nephron 74:390–394
172. Piccoli GB, Ferraresi M, Deagostini MC et al (2013) Vegetarian low-protein diets supplemented with keto analogues: a niche for the few or an option for many? Nephrol Dial Transplant 28:2295–2305
173. McMullen S (2007) Soya protein during pregnancy—an opportunity to attenuate the progression of chronic kidney disease? Br J Nutr 97:4–5
174. Piccoli GB, Clari R, Vigotti FN et al (2015) Vegan–vegetarian diets in pregnancy: danger or panacea? A systematic narrative review. BJOG. 122(5):623–633
175. Craig WJ, Mangels AR (2009) Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc 109:1266–1282
176. Pawlak R, Parrott SJ, Raj S, Cullum-Dugan D, Lucus D (2013) How prevalent is vitamin B12 deficiency among vegetarians? Nutr Rev 71:110–117
177. Koletzko B, Bauer CP, Bung P et al (2012) Nutrition in pregnancy—practice recommendations of the Network “Healthy Start-Young Family Network”. Dtsch Med Wochenschr 137:1366–1372
178. Foster M, Herulah UN, Prasad A, Petocz P, Samman S (2015) Zinc status of vegetarians during pregnancy: a systematic review of observational studies and meta-analysis of zinc intake. Nutrients 7(6):4512–4525
179. Brown MA, Holt JL, Mangos GJ, Murray N, Curtis J, Homer C (2005) Microscopic hematuria in pregnancy: relevance to pregnancy outcome. Am J Kidney Dis 45(4):667–673
180. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365:785–799
181. Shimizu A, Takei T, Moriyama T et al (2010) Effect of kidney disease stage on pregnancy and delivery outcomes among patients with immunoglobulin A nephropathy. Am J Nephrol 32:456–461
182. Ronkainen J, Ala-Houhala M, Autio-Harmainen H et al (2006) Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 21:1266–1273
183. Abe S (1991) Pregnancy in IgA nephropathy. Kidney Int 40(6):1098–1102
184. Liu Y, Ma X, Lv J, Shi S, Liu L, Chen Y, Zhang H (2014) Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study. Am J Kidney Dis 64(5):730–736
185. Oh HJ, Han SH, Yoo DE, Kim SJ, Park JT, Kim JK, Yoo TH, Kang SW, Choi KH (2011) Reduced pre-pregnancy proteinuria is associated with improving postnatal maternal renal outcomes in IgA nephropathy women. Clin Nephrol 76(6):447–454
186. Zand L, Williams A, Babovic-Vuksanovic D, Nwoko R, Cornell L, Garovic V (2014) The Case | Renal dysfunction in a pregnant patient with IgA nephropathy. Kidney Int 85(6):1477–1478
187. Barisoni L, Schnaper HW, Kopp JB (2007) A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2(3):529–542
188. Nishimoto K, Shiiki H, Nishino T et al (1999) Glomerular hypertrophy in preeclamptic patients with focal segmental glomerulosclerosis. A morphometric analysis. Clin Nephrol. 51(4):209–219
189. Kwiatkowski S, Kwiatkowska E, Rzepka R, Kurkiewicz V, Mikołajek-Bedner W, Torbè A (2015) Development of a focal segmental glomerulosclerosis after pregnancy complicated by preeclampsia: case report and review of literature. J Matern Fetal Neonatal Med 29(10):1566–1569
190. Lee HS, Kim TS (1995) A morphometric study of preeclamptic nephropathy with focal segmental glomerulosclerosis. Clin Nephrol 44(1):14–21
191. Kambham N, Markowitz GS, Valeri AM et al (2001) Obesity related glomerulomegaly: an emerging epidemic. Kidney Int 59:1498–1509
192. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP (1999) Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180:114–121
193. Burton PJ, Waddell BJ (1999) Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod 60:234–240
194. van Runnard Heimel PJ, Schobben AF, Huisjes AJ, Franx A, Bruinse HW (2005) The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome. Placenta 26(10):842–845
195. Ronco P, Debiec H (2015) Pathophysiological advances in membranous nephropathy: time for a shift in patient’s care. Lancet 385(9981):1983–1992
196. Tomas NM, Beck LH Jr, Meyer-Schwesinger C et al (2014) Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371(24):2277–2287
197. Packham DK, North RA, Fairley KF, Whitworth JA, Kincaid-Smith P (1987) Membranous glomerulonephritis and pregnancy. Clin Nephrol 28(2):56–64
198. Malik GH, Al-Harbi AS, Al-Mohaya S et al (2002) Repeated pregnancies in patients with primary membranous glomerulonephritis. Nephron. 91(1):21–24
199. Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis: a new look at an old entity. N Engl J Med 366:1119–1131
200. Surian M, Imbasciati E, Cosci P et al (1984) Glomerular disease and pregnancy. A study of 123 pregnancies in patients with primary and secondary glomerular diseases. Nephron. 36(2):101–105
201. Malik GH, Al-Mohaya S, Shaikh JF et al (2001) Repeated pregnancies in patients with non-immunoglobulin a mesangioproliferative glomerulonephritis. Am J Nephrol 21(5):378–382
202. Kurdoglu M, Kurdoglu Z, Adali E, Soyoral Y, Erkoc R (2010) Successful management of membranoproliferative glomerulonephritis type I in pregnancy. Arch Gynecol Obstet 281(1):105–109
203. De Galasso L, Gigante A, Pirozzi N et al (2011) Acute renal failure and nephrotic syndrome due to membranoproliferative nephritis during the second trimester of pregnancy. Clin Nephrol 75(5):480–483
204. Ruiz-Irastorza G, Lima F, Alves J et al (1996) Increased rate of lupus flare during pregnancy and the puerperium, a prospective study of 78 pregnancies. Br J Rheumatol 35:133–138
205. Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, Piette JC (2001) Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis 60:599–604
206. Moroni G, Quaglini S, Banfi G et al (2002) Pregnancy in lupus nephritis. Am J Kideny Dis 40:713–720
207. Moroni G, Ponticelli C (2005) Pregnancy after lupus nephritis. Lupus 14:89–94
208. Carmona F, Font J, Moga I, Lazzaro I, Cervera R, Pac V, Balasch L (2005) Class III–IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 53:182–188
209. Zhang L, Abe K, Hashimoto H, Takasaki Y (2007) Pregnancy and fetal outcomes in patients with lupus nephritis. Nihon Rinsho Meneki Gakkai Kaishi 30:185–192
210. Imbasciati E, Tincani A, Gregorini G et al (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 24:519–525
211. Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, Nelson-Piercy C (2011) Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 38:1906–1913
212. Saavedra MA, Cruz-Reyes C, Vera-Lastra O et al (2012) Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol 31:813–819
213. Petri M, Kim MY, Kalunian KC et al (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550–2558
214. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L et al (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353:2539–2549
215. Fischer-Betz R, Specker C, Brinks R, Aringer M, Schneider M (2013) Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford) 52:1070–1076
216. Ponticelli C, Moroni G (2015) Immunosuppression in pregnant women with systemic lupus erythematosus. Expert Rev Clin Immunol. 11:549–552
217. Leroux M, Desveaux C, Parcevaux M et al (2015) Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study. Lupus 24(13):1384–1391
218. Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al (2012) Maternal hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126:76–82
219. Abarientos C, Sperber K, Shapiro DL et al (2011) Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy. Expert Opin Drug Saf 10:705–714
220. Kaaja R, Julkunen H, Ammälä P, Palosuo T, Kurki P (1993) Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 72:63–66
221. Petri M (2013) Immunosuppressive drug use in pregnancy. Autoimmunity 36:51–56
222. Perricone R, De Carolis C, Kröegler B et al (2008) Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford) 47:646–651
223. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS (2003) Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 101:1319–1332
224. Duley L, Henderson-Smart DJ, Knight M, King JF (2007) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 18(2):CD000492
225. Farquharson RG, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100:408–413
226. Ruffatti A, Salvan E, Del Ross T et al (2014) Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost 112:727–735
227. Chakravarty EF, Colon I, Langen ES et al (2005) Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192:1897–1904
228. Chen CW, Jaffe IZ, Karumanchi SA (2014) Pre-eclampsia and cardiovascular disease. SA Cardiovasc Res 101:579–586
229. Galdman D, Tandon A, Ibañez D, Urowitz MB (2010) The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 37:754–758
230. Hou S (1999) Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 33:235–252
231. Clark CA, Spitzer KA, Laskin CA (2005) Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 32:1709–1712
232. Cimaz R, Spence DL, Hornberger L, Silverman ED (2003) Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 142:678–683
233. Clowse ME, Magder LS, Witter F, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52:514–521
234. Rahman P, Gladman DD, Urowitz MB (1998) Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 25:1526–1530
235. McNeil HP, Chesterman CN, Krilis SA (1991) Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49:193–280
236. Hayslett JP, Lynn RI (1980) Effect of pregnancy in patients with lupus nephropathy. Kidney Int 18:207–220
237. Lateef A, Petri M (2013) Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 27:435–447
238. Doria A, Bajocchi G, Tonon M, Salvarani C (2008) Pre-pregnancy counselling of patients with vasculitis. Rheumatology 47:iii13–iii15
239. Pagnoux C, Le Guern V, Goffinet F et al (2001) Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies. Rheumatology 50:953–961
240. Tuin J, Sanders JSF, de Joode AAE, Stegeman C (2012) Pregnancy in women diagnosed with ANCA-Associated Vasculitis: favorable outcome for mother and child. Arthritis Care Res (Hoboken) 64:539–545
241. Clowse MEB, Richeson RL, Pieper C, Merkel PA, for the Vasculitis Clinical Research Consortium (2013) Pregnancy outcomes among patients with vasculitis. Arthritis Care Res 65(1370):1374
242. Croft AP, Smith SW, Carr S et al (2015) Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis. Kidney Int 87:807–811
243. Sangle SR, Vounotrypidis P, Briley A et al (2015) Pregnancy out come in patients with sistemi vasculitis: a single-centre marched case-control study. Rheumatology (Oxford) 54:1582–1586
244. Soh MC, Nelson-Piercy C (2015) High-risk pregnancy and the rheumatologist. Rheumatology (Oxford) 54(4):572–587
245. Chakravarty EF, Murray ER, Kelman A, Farmer P (2011) Pregnancy outcomes after maternal exposure to rituximab. Blood 117(5):1499–1506
246. Steinke JM, Mauer M (2008) Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Pediatr Endocrinol Rev 5(4):958–963
247. Furukawa T, Tokunaga S, Iwashita K, Sato K, Terashima M, Hora K, Oguchi H, Furuta S, Shigematsu H (1987) Diabetic glomerulosclerosis with nephrotic syndrome in early pregnancy. Nippon Jinzo Gakkai shi 29:541–545
248. Biesenbach G, Zazgornik J (1989) Incidence of transient nephrotic syndrome during pregnancy in diabetic women with and without pre-existing microalbuminuria. Br Med J 299:366–367
249. Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M (1993) Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 82:802–807
250. Coletta J, Simpson LL (2010) Maternal medical disease and stillbirth. Clin Obstet Gynecol 53(3):607–616
251. Ringholm L, Mathiesen ER, Kelstrup L, Damm P (2012) Managing type 1 diabetes mellitus in pregnancy—from planning to breastfeeding. Nat Rev Endocrinol 8:659–667
252. Fretts RC (2005) Etiology and prevention of stillbirth. Am J Obstet Gynecol 193(6):1923–1935
253. Mathiesen ER, Ringholm L, Damm P (2011) Pregnancy management of women with pregestational diabetes. Endocrinol Metab Clin North Am 40(4):727–738
254. Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S, Guideline Development Group (2010) Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 341:c2207
255. Carr DB, Koontz GL, Gardella C, Holing EV, Brateng DA, Brown ZA, Easterling TR (2006) Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypert 19:513–519
256. Niensen LR, Damm P, Mathiesen ER (2009) Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 32(1):38–44
257. Jensen DM, Damm P, Ovesen P, Mølsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Moeller M, Mathiesen ER (2010) Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes. Diabetes Care 33:1
258. Yogev Y, Chen R, Ben-Haroush A, Hod M, Bar J (2010) Maternal overweight and pregnancy outcome in women with type-1 diabetes mellitus and different degrees of nephropathy. J Matern Fetal Neonatal Med 23(9):999–1003
259. Wu M, Wang D, Zand L et al (2015) Pregnancy outcomes in autosomal dominant polycystic kidney disease: a case-control study. J Matern Fetal Neonatal Med 29(5):807–812
260. Chapman AB, Johnson AM, Gabow PA (1994) Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5(5):1178–1185
261. Vora N, Perrone R, Bianchi DW (2008) Reproductive issues for adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 51(2):307–318
262. Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Bryant JI (1983) Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease. Obstet Gynecol 61(5):566–570
263. Backe J, Kristen P, Arlt W, Steck T (1996) Postpartum rupture of a kidney cyst in familial polycystic kidney degeneration and HELLP syndrome. Z Geburtshilfe Neonatol 200(3):122–126
264. Szmigielski W, Klamut M, Caban B, Wieczorek P, Tereszkiewicz J (1988) Superselective arterial embolization in the control of hemorrhage from ruptured cyst in polycystic kidney in pregnancy. Pol Przegl Radiol 52(2):110–111
265. Gigarel N, Frydman N, Burlet P et al (2008) Preimplantation genetic diagnosis for autosomal recessive polycystic kidney disease. Reprod Biomed Online. 16(1):152–158
266. Banks N, Bryant J, Fischer R, Huizing M, Gahl WA, Gunay-Aygun M (2015) Pregnancy in autosomal recessive polycystic kidney disease. Arch Gynecol Obstet 291(3):705–708
267. Nicolle LE (2012) Urinary tract infection in adults. In: Brenner and Rector’s the kidney, 9th edn. Saunders. ISBN: 978-1-4160-6193-9, 36, pp 1356–1382
268. Piccoli GB, Colla L, Burdese M et al (2006) Development of kidney scars after acute uncomplicated pyelonephritis: relationship with clinical laboratory and imaging data at diagnosis. World J Urol 24:66–73
269. Piccoli GB, Consiglio V, Deagostini MC et al (2011) The clinical and imaging presentation of acute “non complicated” pyelonephritis: a new profile for an ancient disease. BMC Nephrol. 15(12):68
270. Lee YJ, Lee JH, Park YS (2012) Risk factors for renal scar formation in infants with first episode of acute pyelonephritis: a prospective clinical study. J Urol 187(3):1032–1036
271. Raz R, Sakran W, Chazan B et al (2003) Long-term follow-up of women hospitalized for acute pyelonephritis. Clin Infect Dis 37:1014–1020
272. Martinell J, Jodal U, Lidin-Janson G (1990) Pregnancies in women with and without renal scarring after urinary infection in childhood. BMJ 300:840
273. Millar LK, Cox SM (1997) Urinary tract infections complicating pregnancy. Infect Dis Clin N Am 11:13–26
274. Stamm WE (1993) Management of urinary tract infection in adults. NEJM 329:1328–1334
275. Castellino S, Cabiddu F, Gernone G et al (2013) Rene e Gravidanza: Suggerimenti di pratica clinica e di applicazione delle Linee-guida. G Ital Nefrol, vol S59, Anno 30, Luglio
276. Nicolle LE (2001) A practical approach to the management of complicated urinary tract infection. Drugs Aging 18:243–254
277. Nowicki B (2002) Urinary tract infection in pregnant women: old dogmas and current concepts regarding pathogenesis. Curr Infect Dis Rep. 4(6):529–535
278. Nowicki B, Sledzinska A, Samet A, Nowicki S (2011) Pathogenesis of gestational urinary tract infection: urinary obstruction versus immune adaptation and microbial virulence. BJOG 118(2):109–112
279. Pastore LM et al (1999) Predictors of urinary tract infection at the first prenatal visit. Epidemiology 10:282
280. Kass EH (1960) Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med 105:194
281. Naeye RL (1979) Causes of the excessive rates of perinatal mortality and prematurity in pregnancies complicated by maternal urinary-tract infections. N Engl J Med 300:819
282. Mittendorf R (1992) Prevention of preterm delivery and low birth weight associated with asymptomatica bacteriuria. Clin Infect Dis 14:927
283. Patterson TF (1997) Detection, significance and therapy of bacteriuria in pregnancy. Infect Dis Clin N Am 11:593
284. Delzell JE Jr (2000) Urinary tract infections during pregnancy. Am Fam Physician 61:713
285. Sheiner E, Mazor-Drey E, Levy A (2009) Asymptomatic bacteriuria during pregnancy. J Matern Fetal Neonatal Med 22(5):423–427
286. Smaill FM, Vasquez JC (2007) Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2:CD000490
287. Guinto VT, De Guia B, Festin MR, Dowswell T (2010) Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy (Review). Cochrane Database Syst Rev 9:CD007855
288. Vasquez JC, Abalos E (2011) Treatments for symptomatic urinary tract infections during pregnancy. CochraneDatabase of Systematic Reviews 1:CD002256
289. Gratacòs E (1994) Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. J Infect Dis 169:1390
290. Villar J (1998) Nutritional and antimicrobial interventions to prevent preterm birth: an overview of randomized controlled trials. Obstet Gynecol Surv 53:575
291. NICE clinical guideline 62 – 2008
292. Rouse DJ (1995) Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost effectiveness and cost benefit analysis. Obstet Gynecol 86:119
293. Honest H et al (2009) Screening to prevent spontaneous preterm birth: systemtic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 13(43):1–627
294. Kass EH (1960) The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: Quinn EL, Kass EH (eds) Biology of pyelonephritis. Little, Brown and Co., Boston, pp 399-412
295. Millar L (2000) Rapid enzymatic urine screening test to detect bacteriuria in pregnancy. Obstet Gynecol 95:601
296. McNair RD (2000) Evaluation of the centrifuged and Gram-steined smear, urinalysis and reagent strip testing to detect asymptomatic bacteriuria in obstetric patients. Am J Obstet Gynecol 182:1076
297. Shelton SD (2001) Urinary interleukin-8 with asymptomatuc bacteriuria in pregnancy. Obstet Gynecol 97:583
298. Hooton TM (2000) A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 343(14):992
299. Lin K, Fajardo K (2008) U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults. Ann Intern Med 149:W20
300. Nicolle LE, Bradley S, Colgan R et al (2005) IDSA guideline for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 40:643–654
301. Lucas MJ, Cunningham FG (1993) Urinary infection in pregnancy. Clin Obstet Gynecol 36(4):855–868
302. Cabiddu F, Castellino S, Daidone G et al (2000) Linee-guida Rene e Gravidanza. G. Ital. Nefrol. 17:24–46
303. Widmer M, Gülmezoglu AM, Mignini L, Roganti A (2011) Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev. 12:CD000491. doi:10.1002/14651858.CD000491.pub2
304. Lumbiganon P, Laopaiboon M, Thinkhamrop J (2010) Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol 22(2):95–99
305. Estebanez A, Pascual R, Gil V, Ortiz F, Santibáñez M, Pérez Barba C (2009) Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. Eur J Clin Microbiol Infect Dis 28(12):1457–1464
306. Keating GM (2013) Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs 73(17):1951–1966
307. Usta TA, Dogan O, Ates U, Yucel B, Onar Z, Kaya E (2011) Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy. Int J Gynaecol Obstet 114(3):229–233
308. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A (2009) The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 34(5):407–413
309. Rodríguez-Baño J, Alcalá JC, Cisneros JM et al (2008) Community infections caused by extended-spectrum beta-lactamase-producing E. coli. Arch Intern Med 168(17):1897–1902
310. Andersen JT (2013) Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. PLoS One 8(1):e53327
311. Stein GE (1998) Single-dose treatment of acute cystitis with fosfomycin tromethamine. Ann Pharmacother 32:215
312. Crider KS (2009) Antibacterial medication use during pregnancy and risk of birth defect: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 163(11):978
313. American College of Obstetricians and Gynecologists Committee on Obstetric Practice (2011) ACOG Committee Opinion no 494. Obstet Gynecol 117(6):1484
314. Nordeng H (2013) Neonatal outcomes after gestational exposure to nitrofurantoin. Obstet Gynecol 121:306–313
315. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343(22):1608–1614
316. Bar-Oz B (2009) The safety of quinolones—a meta-analysis of pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 143(2):75–78
317. Macejko AM, Schaeffer AJ (2007) Asymptomatic bacteriuria and symptomtic urinary tract infections during pregnancy. Urol Clin North Am 34:35–42
318. Hill JB, Sheffield JS, McIntire DD, Wendel GD Jr (2005) Acute pyelonephritis in pregnancy. Obstet Gynecol 105(1):18–23
319. Wing DA, Fassett MJ, Getahun D (2014) Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 210(3):219.e1-6
320. Artero A, Alberola J, Eiros JM, Nogueira JM, Cano A (2013) Pyelonephritis in pregnancy. How adequate is empirical treatment? Rev Esp Quimioter 26(1):30–33
321. Minassian C, Thomas SL, Williams DJ, Campbell O, Smeeth L (2013) Acute maternal infection and risk of pre-eclampsia: a population-based case-control study. PLoS One 8(9):e73047
322. Riley JM, Dudley AG, Semins MJ (2014) Nephrolithiasis and pregnancy: has the incidence been rising? Endourol 28(3):383–386
323. Ross AE, Handa S, Lingeman JE, Matlaga BR (2008) Kidney stones during pregnancy: an investigation into stone composition. Urol Res 36(2):99
324. Smith CL, Kristensen C, Davis M, Abraham PA (2001) An evaluation of the physicochemical risk for renal stone disease during pregnancy. Clin Nephrol 55(3):205–211
325. Butler EL, Cox SM, Cunningham FG (2000) Symptomatic nephrolithiasis complicating pregnancy. Obstet Gynecol 96:573
326. McAleer SJ, Loughlin KR (2004) Nephrolithiasis and pregnancy. Curr Opin Urol 14:123
327. Elgamasy A, Elsherif A (2010) Use of Doppler ultrasonography and rigid ureteroscopy for managing symptomatic ureteric stones during pregnancy. BJU Int 106:262
328. Fulgham PF, Assimos DG, Pearle MS, Preminger GM (2013) Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol 189:1203
329. Semins MJ, Trock BJ, Matlaga BR (2009) The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis. J Urol 181:139
330. Watterson JD, Girvan AR, Beiko DT et al (2002) Ureteroscopy and holmium: YAG laser lithotripsy: an emerging definitive management strategy for symptomatic ureteral calculi in pregnancy. Urology 60:383
331. Adanur S, Ziypak T, Bedir F et al (2014) Ureteroscopy and holmium laser lithotripsy: is this procedure safe in pregnant women with ureteral stones at different locations? Arch Ital Urol Androl. 86(2):86–89
332. Piccoli GB, Attini R, Parisi S et al (2013) Excessive urinary tract dilatation and proteinuria in pregnancy: a common and overlooked association? BMC Nephrol. 27(14):52
333. Piccoli GB, Attini R, De Pascale A et al (2012) Protean presentation and multiple challenges of nephrocalcinosis in pregnancy (six pregnancies in four patients). Nephrol Dial Transplant 27(3):1131–1138
334. Lewis DF, Robichaux AG, Jaekle RK et al (2003) Urolithiasis in pregnancy. Diagnosis, management and pregnancy outcome. J Reprod Med 48:28–32
335. Swartz MA, Lydon-Rochelle MT, Simon D et al (2007) Admission for nephrolithiasis in pregnancy and risk of adverse birth outcomes. Obstet Gynecol 109:1099
336. Rosenberg E, Sergienko R, Abu-Ghanem S et al (2011) Nephrolithiasis during pregnancy: characteristics, complications, and pregnancy outcome. World J Urol 29:743–747
337. Banhidy F, Acs N, Puho EH et al (2007) Maternal kidney stones during pregnancy and adverse birth outcomes, particularly congenital abnormalities in the offspring. Arch Gynecol Obstet 275:481–487
338. Jungers P, Houillier P, Chauveau D et al (1996) Pregnancy in women with reflux nephropathy. Kidney Int. 50(2):593–599
339. North RA, Taylor RS, Gunn TR (2000) Pregnancy outcome in women with reflux nephropathy and the inheritance of vesico-ureteric reflux. Aust N Z J Obstet Gynaecol 40(3):280–285
340. www.fda.gov. Accessed 20 June 2014
341. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(Suppl 3):S1–S155
342. EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 17(Suppl 4):50–55
343. Østensen M, Khamashta M, Lockshin M et al (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8:209
344. Bar Oz B, Hackman R, Einarson T, Koren G (2001) Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 71:1051–1055
345. Kainz A, Harabacz I, Cowlrick IS et al (2000) Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 70:1718–1721
346. Park-Wyllie L, Mazzotta P, Pastuszak A et al (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385–392
347. Sifontis NM, Coscia LA, Constantinescu S et al (2006) Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82:1698–1702
348. Anderka MT, Lin AE, Abuelo DN et al (2009) Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A 149:1241–1248
349. Framarino-dei-Malatesta M, Derme M, Manzia TM et al (2013) Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature. Expert Rev Clin Immunol 9:781–789
350. Stokholm J, Schjørring S, Pedersen L et al (2013) Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS One 8(12):e82932
351. Martinez de Tejada B (2014) Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health 11(8):7993–8009
352. Thinkhamrop J, Hofmeyr GJ, Adetoro O, Lumbiganon P, Ota E (2015) Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity. Cochrane Database Syst Rev 6:CD002250
353. Nahum GG, Uhl K, Kennedy DL (2006) Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 107(5):1120–1138
354. Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M (2015) Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci 11(1):67–77
355. Grandone E, Villani M, Tiscia GL (2015) Aspirin and heparin in pregnancy. Expert Opin Pharmacother 16(12):1793–1803
356. Guyatt GH, Akl EA, Crowther M et al (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):7–47
357. Reisenberger K, Egarter C, Kapiotis S et al (1997) Transfer of erythropoietin across the placenta perfused in vitro. Obstet Gynecol 89(5 Pt 1):738–742
358. Krafft A, Bencaiova G, Breymann C (2009) Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone. Fetal Diagn Ther 25(2):239–245
359. Torrance HL, Benders MJ, Derks JB et al (2009) Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 124(1):350–357
360. Hoeltzenbein M, Stieler K, Panse M et al (2013) Allopurinol use during pregnancy—outcome of 31 prospectively ascertained cases and a phenotype possibly indicative for teratogenicity. PLoS One 8(6):e66637
361. De-Regil LM, Palacios C, Ansary A et al (2012) Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev 2:CD008873
362. Lawlor DA, Wills AK, Fraser A et al (2013) Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study. Lancet 381:2176
363. IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D. The National Academies Press, Washington
364. Misra M, Pacaud D, Petryk A et al (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2):398–417
365. Wagner CL, Greer FR, The Section on Breastfeeding and Committee on Nutrition (2008) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122(5):1142–1152
366. ACOG Committee on Obstetric Practice (2011) ACOG Committee Opinion No. 495: vitamin D: screening and supplementation during pregnancy. Obstet Gynecol 118(1):197–198
367. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. (2011) Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline (published correction appears in J Clin Endocrinol Metab 2011;96(12):3908). J Clin Endocrinol Metab. 2011;96(7):1911–1930
368. Piccoli GB, Cabiddu G, Attini R et al (2015) Pregnancy in chronic kidney disease: questions and answers in a changing panorama. Best Pract Res Clin Obstet Gynaecol 29(5):625–642
369. Chakravarty EF, Murray ER, Kelman A, Farmer P (2011) Pregnancy outcomes after maternal exposure to rituximab. Blood 117(5):1499–1506
370. Klink DT, van Elburg RM, Schreurs MW, van Well GT (2008) Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol. 2008:271363. doi:10.1155/2008/271363